Caris Life Sciences, Inc.
CAI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $56 | $107 | $54 |
| Short-Term Investments | $2 | $65 | $302 | $79 |
| Receivables | $88 | $55 | $40 | $144 |
| Inventory | $40 | $49 | $47 | $0 |
| Other Curr. Assets | $22 | $17 | $19 | -$62 |
| Total Curr. Assets | $216 | $243 | $516 | $215 |
| Property Plant & Equip (Net) | $103 | $148 | $138 | $1,781 |
| Goodwill | $19 | $19 | $19 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $3 | $44 | $617 |
| Total NC Assets | $128 | $170 | $201 | $2,398 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $344 | $413 | $717 | $2,613 |
| Liabilities | – | – | – | – |
| Payables | $28 | $27 | $27 | $4 |
| Short-Term Debt | $66 | $7 | $57 | $183 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $6 | $1 | $3 |
| Other Curr. Liab. | $64 | $56 | $51 | $130 |
| Total Curr. Liab. | $165 | $95 | $137 | $320 |
| LT Debt | $358 | $211 | $214 | $1,562 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $24 |
| Other NC Liab. | $2,319 | $2,252 | $2,069 | $3 |
| Total NC Liab. | $2,677 | $2,463 | $2,283 | $1,590 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $45 | $51 | $49 | $0 |
| Total Liabilities | $2,843 | $2,558 | $2,420 | $1,910 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $104 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,472 | -$2,119 | -$1,679 | $503 |
| AOCI | $0 | $0 | $2 | -$6 |
| Other Equity | -$27 | -$26 | -$25 | $101 |
| Total Equity | -$2,499 | -$2,145 | -$1,702 | $702 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $344 | $413 | $717 | $2,613 |
| Net Debt | $360 | $161 | $164 | $1,692 |